Litcius/Paper detail

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial

Thierry Conroy, Jean-François Bosset, Pierre-Luc Etienne, Emmanuel Rio, Éric François, Nathalie Mesgouez‐Nebout, V. Vendrely, Xavier Artignan, Olivier Bouché, D. Gargot, Valérie Boige, Nathalie Bonichon-Lamichhane, Christophe Louvet, Clotilde Morand, Christelle de la Fouchardière, Najib Lamfichekh, Béata Juzyna, Claire Jouffroy-Zeller, Éric Rullier, Frédéric Marchal, Sophie Gourgou, Florence Castan, Christophe Borg, Christophe Borg, Pierre-Luc Etienne, Emmanuel Rio, Nathalie Mesgouez‐Nebout, Éric François, V. Vendrely, Thierry Conroy, Xavier Artignan, Olivier Bouché, D. Gargot, Valérie Boige, Nathalie Bonichon-Lamichhane, Christophe Louvet, Clotilde Morand, Christelle de la Fouchardière, Philippe Ronchin, Jean‐François Seitz, Stéphane Corbinais, Emmanuel Maillard, Monique Noirclerc, Farid El Hajbi, Philippe Ronchin, Anne-Laure Villing, Y. Bécouarn, Lam Foong Fat Lam Kam Sang, Pascal Artru, Jean‐Baptiste Bachet, Fayçal Hocine, Catherine Ligeza‐Poisson, Claire Vautravers, Méher Ben Abdelghani, Thomas Aparicio, Elise Desot, Isabelle Marquis

2021The Lancet Oncology1,282 citationsDOI

Topics & Concepts

MedicineOxaliplatinCapecitabineFOLFIRINOXChemotherapyTotal mesorectal excisionChemoradiotherapyColorectal cancerIrinotecanFluorouracilEpirubicinNeoadjuvant therapySurgeryFebrile neutropeniaFOLFOXInternal medicineNeutropeniaCancerBreast cancerCyclophosphamideColorectal Cancer Surgical TreatmentsColorectal and Anal CarcinomasEsophageal Cancer Research and Treatment